Patents by Inventor Tracee Gruber

Tracee Gruber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acellular regenerative products and methods of their manufacture
    Patent number: 12551509
    Abstract: An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. The product may include various scaffolding such as biomaterials or human tissue, and the scaffolding may be infused with various plasmas and agents. The cell-free treatment may maintain the biological activity of many therapeutic agents found within cells and may possess multiple structural components to support cellular attachment. The structural components or scaffolds may function as a reservoir of highly diffusible chemotactic and cellular-programming factors that may be useful to treat injury and disease.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: February 17, 2026
    Assignee: Lucina Patent Holdco, LLC
    Inventors: Ryan Dregalla, Leonard R. Duford, Dean Nistal, Tracee Gruber
  • ACELLULAR REGENERATIVE PRODUCTS AND METHODS OF THEIR MANUFACTURE
    Publication number: 20180325961
    Abstract: An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. The product may include various scaffolding such as biomaterials or human tissue, and the scaffolding may be infused with various plasmas and agents. The cell-free treatment may maintain the biological activity of many therapeutic agents found within cells and may possess multiple structural components to support cellular attachment. The structural components or scaffolds may function as a reservoir of highly diffusible chemotactic and cellular-programming factors that may be useful to treat injury and disease.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Inventors: Ryan Dregalla, Leonard R. Duford, Dean Nistal, Tracee Gruber
  • ACELLULAR REGENERATIVE PRODUCTS AND METHODS OF THEIR MANUFACTURE
    Publication number: 20180325962
    Abstract: An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. The product may include various scaffolding such as biomaterials or human tissue, and the scaffolding may be infused with various plasmas and agents. The cell-free treatment may maintain the biological activity of many therapeutic agents found within cells and may possess multiple structural components to support cellular attachment. The structural components or scaffolds may function as a reservoir of highly diffusible chemotactic and cellular-programming factors that may be useful to treat injury and disease.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Inventors: Ryan Dregalla, Leonard R. Duford, Dean Nistal, Tracee Gruber